ValuEngine upgraded shares of Imperva (NASDAQ:IMPV) from a sell rating to a hold rating in a research report report published on Thursday.
Other equities analysts have also recently issued reports about the company. KeyCorp reissued a hold rating on shares of Imperva in a report on Tuesday, October 24th. Oppenheimer reissued a buy rating and issued a $55.00 target price on shares of Imperva in a report on Thursday, November 9th. Evercore ISI reissued a buy rating and issued a $56.00 target price on shares of Imperva in a report on Wednesday, November 8th. Piper Jaffray Companies raised Imperva from a neutral rating to an overweight rating and set a $52.00 target price for the company in a report on Friday, February 9th. Finally, JPMorgan Chase & Co. cut Imperva from a neutral rating to an underweight rating and set a $45.00 target price for the company. in a report on Tuesday, December 12th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of Buy and an average target price of $53.14.
Imperva (IMPV) opened at $46.10 on Thursday. Imperva has a twelve month low of $37.17 and a twelve month high of $52.40. The stock has a market capitalization of $1,568.04, a P/E ratio of 67.79 and a beta of 1.79.
Hedge funds have recently added to or reduced their stakes in the stock. New York State Common Retirement Fund increased its holdings in Imperva by 5.3% during the 2nd quarter. New York State Common Retirement Fund now owns 35,800 shares of the software maker’s stock valued at $1,713,000 after purchasing an additional 1,793 shares in the last quarter. Prudential Financial Inc. increased its holdings in Imperva by 80.7% during the 3rd quarter. Prudential Financial Inc. now owns 54,174 shares of the software maker’s stock valued at $2,351,000 after purchasing an additional 24,190 shares in the last quarter. Wells Fargo & Company MN increased its holdings in Imperva by 11.9% during the 3rd quarter. Wells Fargo & Company MN now owns 213,953 shares of the software maker’s stock valued at $9,285,000 after purchasing an additional 22,741 shares in the last quarter. American Century Companies Inc. acquired a new stake in Imperva during the 3rd quarter valued at $6,832,000. Finally, Bank of New York Mellon Corp increased its holdings in Imperva by 10.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 150,752 shares of the software maker’s stock valued at $6,542,000 after purchasing an additional 14,727 shares in the last quarter. 95.91% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: “Imperva (IMPV) Upgraded to Hold at ValuEngine” was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at https://www.com-unik.info/2018/02/19/imperva-impv-upgraded-to-hold-at-valuengine.html.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.